All In Biotech

Drug Trial Radar · NCT01241214

Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis

A Multi-center, Double-blind, Randomized, Placebo-controlled, Active Reference, Parallel-group, Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis

Last checked: Nov 20, 2026Latest source record: May 15, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 579 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

579

Actual

Start

Nov 2010

Primary completion

Feb 2011

Study completion Feb 2011

Sponsor

Lead sponsor
Idorsia Pharmaceuticals Ltd.Industry
Sponsor type
Industry
First posted
Nov 16, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will assess the efficacy and safety of different doses of ACT-129968 in adult patients with seasonal allergic rhinitis, due to mountain cedar pollen.

Conditions

  • Seasonal Allergic Rhinitis

Interventions

  • ACT-129968Drug

    ACT-129968 (Dose 1, Dose 2, or Dose 3) or matching placebo administered orally twice daily

  • ACT-129968Drug

    ACT-129968 (Dose 4) \& matching placebo administered orally once daily

  • CetirizineDrug

    Ceterizine administered once daily

  • PlaceboDrug

    Matching placebo administered twice daily.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To demonstrate a change in Daytime Nasal Symptom Score while taking Dose 3 of ACT-129968 versus placeboTime frame: Baseline to week 2

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Clinical Investigative Site 7905

    Austin, Texas

  • Clinical Investigative Site 7907

    Kerrville, Texas

  • Clinical Investigative Site 7903

    New Braunfels, Texas

  • Clinical Investigative Site 7901

    San Antonio, Texas

  • Clinical Investigative Site 7902

    San Antonio, Texas

  • Clinical Investigative Site 7904

    San Antonio, Texas

  • Clinical Investigative Site 7906

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.